Given the importance of CD8+ T cells as effectors for eliminating cancer cells, we evaluated the co-expression of IFNγ and GZMb in CD8+ TILs—two commonly used markers to indicate their activation status and antitumoral activities29. The gene discussed is CD8A; the disease is cancer.